Christos Mantzoros

Christos Mantzoros, MD, DSc is a Professor of Medicine at Harvard Medical School, Chief of Endocrinology, Diabetes and Metabolism at the Boston VA Healthcare System, and Director of Human Nutrition at Beth Israel Deaconess Medical Center (BIDMC). He has also served as Professor of Environmental Health at the Harvard School of Public Health and Professor of Medicine at Boston University School of Medicine. His career spans clinical practice, groundbreaking research, and extensive mentorship in endocrinology, metabolism, and nutrition.

Dr. Mantzoros is a world-renowned expert in leptin and adipokine research, ranked number 1 globally in leptin research and number 2 in adiponectin research by ExpertScape. His primary research interests include energy homeostasis, obesity, diabetes, metabolic dysfunction-associated steatotic liver disease (MASLD), and the role of adipokines in metabolic regulation. He has published over 1,100 scientific papers with more than 168,800 citations and an H-index of 157, making him one of the most cited researchers in his field.

His recent publications (2024-2025) demonstrate a continued focus on metabolic disorders, particularly MASLD/MASH diagnostics and treatment, obesity pharmacotherapies, adipokine physiology, and precision medicine approaches. His work spans basic science, translational research, and clinical trials, with increasing integration of artificial intelligence for diagnostic applications and emphasis on global health implications of metabolic disorders.

Scientific Awards and Recognition

• Highly Cited Researcher by Clarivate (2020-2023)
• 2017 Obesity Society TOPS Award
• 2018 Endocrine Society Outstanding Clinical Investigator Award
• 2018 European Society of Endocrinology Geoffrey Harris Prize
• 2020 American Society of Nutrition's E. V. McCollum Award
• Frontiers in Science Award by the American Association of Clinical Endocrinology

Dr. Mantzoros has mentored over 185 individuals, including 16 full professors and numerous academic and industry leaders. He has secured more than $40 million in direct research funding from NIH, Department of Defense, foundations, and industry over his 26-year career. His laboratory conducts both basic and translational research, having participated in or led more than 135 clinical trials. He currently serves as Editor-in-Chief of the journal Metabolism, which has risen to a 2-year impact factor of 10.8 under his leadership.